Clinical Scorecard: Experiences of Patients Using GLP-1 Receptor Agonists
At a Glance
Category
Detail
Condition
Key Mechanisms
Efficacy in weight reduction and glycemic control through effects on metabolic pathways involved in glucose homeostasis, insulin sensitivity, and central pathways regulating appetite and satiety.
Target Population
Care Setting
Key Highlights
Qualitative research on patient experiences with GLP-1 RAs is limited, particularly regarding those prescribed for obesity.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor for adverse effects and individual efficacy, including regular assessments every 3 months.
Risks
Patient & Prescribing Data
Adults across the US, with diverse racial and ethnic backgrounds.
Participants reported varied experiences, including reasons for discontinuation such as adverse effects and pregnancy.
Clinical Best Practices
Incorporate patient feedback into management practices and emphasize individualized treatment plans.
Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.
